Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ET: Platinum vs Non-platinum in ERCC1 Stratified NSCLC
NCT00801736Phase 3Terminated
- Sponsor
- University College London
- Start
- Oct 2009
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, paclitaxel in non-small cell lung cancer (NSCLC), sponsored by University College London. Started Oct 2009; status: terminated.
02
Drugs
cisplatinpaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00801736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801736.